跳至主要内容
临床试验/IRCT2016062623705N6
IRCT2016062623705N6已完成未知

The effect and no effect of augmentation of Gabapentin and Memantine with Selective Serotonin Reuptake Inhibitors (SSRIs) in treatment of patients with Obsessive Compulsive Disorder (OCD).

Vice Chancellor for Research Affairs, Kermanshah University of Medical Sciences , Kermanshah Univers0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 40 years(—)
性别
All

入选标准

  • Diagnosis of obsessive-compulsive disorder according to the DSM-5 by psychologist; patients that their first reference for treatment or at least one month from cutting drug treatment is passed; Age range 20-40 years.
  • Exclusion criteria: History of organic disease Seizures, diabetes, liver or kidney failure, hypothyroidism; Concomitant use of cardiac medications, Blood pressure, hormones, thyroid; Having other major psychiatric disease and substance abuse; Medical allergy to SSRI, Memantine with Gabapentin; Unwillingness participate in the study; Require hospitalization or receive ECT.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research Affairs, Kermanshah University of Medical Sciences , Kermanshah Univers

相似试验